sb 203580 has been researched along with Cancer of Skin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, DY; Guo, L; Liu, ZM; Wang, M; Ye, L; Zhou, L; Zhou, W | 1 |
| Athar, M; Back, JH; Bickers, DR; Hosseini, M; Kim, AL; Liu, L; Mahfouf, W; Raad, H; Ragi, G; Rezvani, HR; Tang, X; Zhu, Y | 1 |
| Boldt, S; Kolch, W; Weidle, UH | 1 |
| Cho, D; Hahm, E; Hur, D; Hwang, YI; Kang, JS; Kim, D; Kim, S; Kim, YI; Kim, YS; Lee, WJ; Pang, S; Park, H; Park, JH; Yang, Y | 1 |
4 other study(ies) available for sb 203580 and Cancer of Skin
| Article | Year |
|---|---|
Molecular mechanism for P38 signaling pathway in autophagy of skin cancer cell line HS-1.
Topics: Aminoimidazole Carboxamide; Autophagy; Cell Line, Tumor; Enzyme Activation; Humans; Imidazoles; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Pyridines; Ribonucleotides; Signal Transduction; Skin Neoplasms; Ultraviolet Therapy | 2018 |
Inhibition of p38 MAPK signaling augments skin tumorigenesis via NOX2 driven ROS generation.
Topics: Animals; Carcinogenesis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Gene Expression Regulation, Enzymologic; Humans; Imidazoles; Keratinocytes; MAP Kinase Signaling System; Membrane Glycoproteins; Mice; Mice, Knockout; Microarray Analysis; NADPH Oxidase 2; NADPH Oxidases; Pyridines; Reactive Oxygen Species; Skin Neoplasms; Tumor Suppressor Protein p53; Ultraviolet Rays | 2014 |
The role of MAPK pathways in the action of chemotherapeutic drugs.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carcinoma, Squamous Cell; Cell Cycle; Ceramides; Enzyme Activation; Enzyme Inhibitors; Etoposide; Female; Flavonoids; HeLa Cells; Humans; Imidazoles; MAP Kinase Signaling System; Microtubules; Mitogen-Activated Protein Kinases; Neoplasm Proteins; Paclitaxel; Pyridines; Skin Neoplasms; Topoisomerase II Inhibitors; Tumor Cells, Cultured; Tumor Stem Cell Assay | 2002 |
Vitamin C downregulates interleukin-18 production by increasing reactive oxygen intermediate and mitogen-activated protein kinase signalling in B16F10 murine melanoma cells.
Topics: Acetylcysteine; Animals; Antioxidants; Ascorbic Acid; Blotting, Western; Cell Line, Tumor; Densitometry; Down-Regulation; Enzyme Inhibitors; Flow Cytometry; Imidazoles; Immunoprecipitation; Interleukin-18; MAP Kinase Signaling System; Melanoma; Mice; p38 Mitogen-Activated Protein Kinases; Pyridines; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Skin Neoplasms; Time Factors | 2003 |